Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.Materials and Methods The records of 1,095 patients treated with RNU performed at our hospital between 1994...
Saved in:
Published in | Cancer research and treatment Vol. 53; no. 3; pp. 795 - 802 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
Korean Cancer Association
01.07.2021
대한암학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1598-2998 2005-9256 2005-9256 |
DOI | 10.4143/crt.2020.919 |
Cover
Abstract | Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.Materials and Methods The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)–free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).Results The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy–free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.Conclusion Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes. |
---|---|
AbstractList | This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.PURPOSEThis study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)-free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).MATERIALS AND METHODSThe records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)-free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy-free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.RESULTSThe mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy-free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes.CONCLUSIONIntramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes. This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma. The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)-free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS). The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy-free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis. Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes. Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.Materials and Methods The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)–free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).Results The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy–free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.Conclusion Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes. KCI Citation Count: 0 Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper tract urothelial carcinoma.Materials and Methods The records of 1,095 patients treated with RNU performed at our hospital between 1994 and 2018 were retrospectively reviewed; 856 patients with no bladder tumor history were enrolled in the present study. The management of bladder cuff was divided into two categories: extravesical ligation (EL) or transvesical resection (TR). Survival was analyzed using the Kaplan-Meier method and Cox regression analyses were performed to determine which factors were associated with intravesical recurrence (IVR)–free survival (IVRFS), cancer-specific survival (CSS), and overall survival (OS).Results The mean patient age was 64.8 years and the median follow-up was 37.7 months. Among the 865 patients, 477 (55.7%) underwent the TR and 379 (44.3%) the EL. Significantly higher IVRFS (p=0.001) and OS (p=0.013) were observed in the TR group. In multivariable analysis, IVR, CSS, and OS were independently associated with the EL. Among 379 patients treated with the EL, eight underwent remnant ureterectomy. Based on radical cystectomy–free survival, significant difference was not observed between the two groups. However, significantly higher IVRFS was observed in the TR group when the tumor was located in the renal pelvis.Conclusion Intramural complete excision of the distal ureter during RNU should be the gold standard approach compared with EL for the management of distal ureter in terms of oncological outcomes. |
Author | Kim, Taejin Jeong, Byong Chang Jeon, Seong Soo Ryoo, Hyunsoo Sung, Hyun Hwan Seo, Seong Il Lee, Hyun Moo Kim, Jungyu Kang, Minyong Jeon, Hwang Gyun |
Author_xml | – sequence: 1 givenname: Hyunsoo surname: Ryoo fullname: Ryoo, Hyunsoo – sequence: 2 givenname: Jungyu surname: Kim fullname: Kim, Jungyu – sequence: 3 givenname: Taejin surname: Kim fullname: Kim, Taejin – sequence: 4 givenname: Minyong surname: Kang fullname: Kang, Minyong – sequence: 5 givenname: Hwang Gyun surname: Jeon fullname: Jeon, Hwang Gyun – sequence: 6 givenname: Byong Chang surname: Jeong fullname: Jeong, Byong Chang – sequence: 7 givenname: Seong Il surname: Seo fullname: Seo, Seong Il – sequence: 8 givenname: Seong Soo surname: Jeon fullname: Jeon, Seong Soo – sequence: 9 givenname: Hyun Moo surname: Lee fullname: Lee, Hyun Moo – sequence: 10 givenname: Hyun Hwan surname: Sung fullname: Sung, Hyun Hwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33421984$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738741$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNptkktvEzEURi1URNPCjjXyEqRO8Gsy4w1SiVqoVBEpStaW47ETU8_cweMp6l_gV9dJSgWI1ZXlc8_14ztDJx10FqG3lEwFFfyjiWnKCCNTSeULNGGElIVk5ewETWgp64JJWZ-is2H4TshM8Iq-QqecC0ZlLSbo15Vz1qQBg8NzaPtgk8Wfg24aG_F8dA4vbQv3OmDo8KIzEGDrTV4uxmSgtQO-hhDgp--2eKmbw9Y32-8ijDGrYnZD-4AdRLzu--xcRW0SXkdIOxt8puc6Gt9Bq1-jl06Hwb55qudofX21mn8tbhdfbuaXt4Xhok5FKZqa5ZsRISnhgjd6xpk2jklLialmrjGESKOlIY10ZrOxnBFZu6oURLuN4efow9HbRafujFeg_aFuQd1Fdblc3aj8NoKRKrOfjmw_blrbGNulqIPqo291fDh0_r3T-V323KuaSUorkQXvnwQRfox2SKr1g7Eh6M7COCgmqlldclbv0Xd_znoe8vuzMnBxBEyEYYjWPSOUqH0WVM6C2mdB5SxknP2DG5908rA_qQ__b3oEYaO6og |
CitedBy_id | crossref_primary_10_1016_j_urolonc_2024_06_001 crossref_primary_10_2340_sju_v59_25973 crossref_primary_10_3389_fonc_2022_948223 crossref_primary_10_3389_fruro_2022_903693 crossref_primary_10_1007_s00345_024_05185_w crossref_primary_10_3389_fonc_2024_1442168 crossref_primary_10_4143_crt_2023_1219 crossref_primary_10_23736_S2724_6051_23_05448_4 |
Cites_doi | 10.1016/j.urology.2003.12.003 10.1016/j.eururo.2009.12.032 10.1016/j.ijsu.2020.01.016 10.1371/journal.pone.0139976 10.1016/j.juro.2008.10.032 10.1097/01.ju.0000148851.68215.93 10.1016/s0022-5347(17)59324-6 10.1089/end.2006.0374 10.1016/j.eururo.2009.12.001 10.1007/s00345-012-0915-0 10.5489/cuaj.1985 10.1016/j.urolonc.2009.06.003 10.1016/j.eururo.2010.12.042 10.1111/j.1464-410x.2010.09835.x 10.1016/j.eururo.2017.07.036 10.1016/s0022-5347(17)55269-6 10.1002/1097-0142(197611)38 10.1016/s0022-5347(17)55935-2 10.1016/j.urolonc.2013.08.032 10.1016/s0302-2838(01)00002-1 10.1089/end.2006.0306 10.1016/s0022-5347(17)62008-1 10.1089/end.2018.0819 10.1002/cncr.24135 10.1016/j.euf.2018.09.007 10.1016/j.eururo.2012.04.052 10.1016/s0022-5347(05)67019-x 10.1016/j.eururo.2013.03.032 |
ContentType | Journal Article |
Copyright | Copyright © 2021 by the Korean Cancer Association 2021 |
Copyright_xml | – notice: Copyright © 2021 by the Korean Cancer Association 2021 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM ACYCR |
DOI | 10.4143/crt.2020.919 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2005-9256 |
EndPage | 802 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9844207 PMC8291174 33421984 10_4143_crt_2020_919 |
Genre | Journal Article |
GroupedDBID | --- 29B 5-W 53G 8JR 9ZL AAYXX ABDBF ACUHS ACYCR ADBBV AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION DIK E3Z EBD EF. F5P HYE OK1 RPM TR2 C1A CGR CUY CVF ECM EIF NPM 7X8 5PM 08R M~E |
ID | FETCH-LOGICAL-c348t-54d8215904910343da632acf29e10c76fdc009ca9c0d9fcbbe32098f7540afbc3 |
ISSN | 1598-2998 2005-9256 |
IngestDate | Tue Nov 21 21:35:44 EST 2023 Thu Aug 21 14:32:11 EDT 2025 Fri Jul 11 15:23:07 EDT 2025 Thu Apr 03 06:59:54 EDT 2025 Thu Apr 24 22:54:40 EDT 2025 Tue Jul 01 03:18:50 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Oncological outcome Bladder cuff method Upper tract urothelial carcinoma |
Language | English |
License | This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c348t-54d8215904910343da632acf29e10c76fdc009ca9c0d9fcbbe32098f7540afbc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8291174 |
PMID | 33421984 |
PQID | 2476853284 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9844207 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8291174 proquest_miscellaneous_2476853284 pubmed_primary_33421984 crossref_primary_10_4143_crt_2020_919 crossref_citationtrail_10_4143_crt_2020_919 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-07-01 |
PublicationDateYYYYMMDD | 2021-07-01 |
PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Cancer research and treatment |
PublicationTitleAlternate | Cancer Res Treat |
PublicationYear | 2021 |
Publisher | Korean Cancer Association 대한암학회 |
Publisher_xml | – name: Korean Cancer Association – name: 대한암학회 |
References | ref13 ref12 ref15 ref14 ref30 ref11 ref10 ref1 ref17 ref16 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref21 McCarron (ref22) 1983 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 Gupta (ref2) 2008 |
References_xml | – ident: ref18 doi: 10.1016/j.urology.2003.12.003 – ident: ref12 doi: 10.1016/j.eururo.2009.12.032 – ident: ref20 doi: 10.1016/j.ijsu.2020.01.016 – ident: ref28 doi: 10.1371/journal.pone.0139976 – ident: ref14 doi: 10.1016/j.juro.2008.10.032 – ident: ref17 doi: 10.1097/01.ju.0000148851.68215.93 – start-page: 75 volume-title: Tumors of the renal pelvis and ureter: current concepts and management year: 1983 ident: ref22 – ident: ref27 doi: 10.1016/s0022-5347(17)59324-6 – ident: ref16 doi: 10.1089/end.2006.0374 – start-page: 127 volume-title: Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting year: 2008 ident: ref2 – ident: ref13 doi: 10.1016/j.eururo.2009.12.001 – ident: ref4 doi: 10.1007/s00345-012-0915-0 – ident: ref21 doi: 10.5489/cuaj.1985 – ident: ref6 doi: 10.1016/j.urolonc.2009.06.003 – ident: ref8 doi: 10.1016/j.eururo.2010.12.042 – ident: ref10 doi: 10.1111/j.1464-410x.2010.09835.x – ident: ref11 doi: 10.1016/j.eururo.2017.07.036 – ident: ref23 doi: 10.1016/s0022-5347(17)55269-6 – ident: ref26 doi: 10.1002/1097-0142(197611)38 – ident: ref24 doi: 10.1016/s0022-5347(17)55935-2 – ident: ref1 doi: 10.1016/j.urolonc.2013.08.032 – ident: ref19 doi: 10.1016/s0302-2838(01)00002-1 – ident: ref15 doi: 10.1089/end.2006.0306 – ident: ref25 doi: 10.1016/s0022-5347(17)62008-1 – ident: ref5 doi: 10.1089/end.2018.0819 – ident: ref29 doi: 10.1002/cncr.24135 – ident: ref30 doi: 10.1016/j.euf.2018.09.007 – ident: ref7 doi: 10.1016/j.eururo.2012.04.052 – ident: ref3 doi: 10.1016/s0022-5347(05)67019-x – ident: ref9 doi: 10.1016/j.eururo.2013.03.032 |
SSID | ssj0064371 |
Score | 2.2609522 |
Snippet | Purpose This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for... This study aimed to evaluate the effects of bladder cuff method on oncological outcomes in patients who underwent radical nephroureterectomy (RNU) for upper... |
SourceID | nrf pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 795 |
SubjectTerms | Aged Carcinoma, Transitional Cell - mortality Carcinoma, Transitional Cell - secondary Carcinoma, Transitional Cell - surgery Disease-Free Survival Female Follow-Up Studies Humans Kaplan-Meier Estimate Kidney - pathology Kidney - surgery Kidney Neoplasms - mortality Kidney Neoplasms - pathology Kidney Neoplasms - surgery Male Middle Aged Nephroureterectomy - methods Original Retrospective Studies Ureter - pathology Ureter - surgery Ureteral Neoplasms - mortality Ureteral Neoplasms - pathology Ureteral Neoplasms - surgery Urinary Bladder - pathology Urinary Bladder - surgery Urinary Bladder Neoplasms - epidemiology Urinary Bladder Neoplasms - prevention & control Urinary Bladder Neoplasms - secondary 의학일반 |
Title | Effects of Complete Bladder Cuff Removal on Oncological Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/33421984 https://www.proquest.com/docview/2476853284 https://pubmed.ncbi.nlm.nih.gov/PMC8291174 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002738741 |
Volume | 53 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Cancer Research and Treatment, 2021, 53(3), , pp.795-802 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb5swFLZ6maa9TLsvu8mb5qeIjmCD7UeSJuomtX1ppL4hMLBVbSGiySbtJ-xX7xwwhPQidXtBln1im3wf9jlwzjEhnzmYACLNucOTWDki8X0HzCDfCWB7UrnhmRejoXh4FBzMxbdT_3Rr-0HPa2m1TPbM71vjSv4HVagDXDFK9h-Q7TqFCigDvnAFhOF6L4yna2cMfK4Bgmw4vsC1pBpOVjmmGbksf6K6WQyPC9Otc8erJUwnuxrOgAXlr9oDL24-2BxlCzy5p0IvGXyhf9k4dM4XC-jzBEOqhvMKo7Yu8FX7BE8iKkq7tq8THhgQtmmEmsi5zp-9BZhNxyz0mVZsuo9XJdh0wpRiWq1FQjbW6IoBLaGoC1AjmZ7cIrLPFIeWWlYyJTZEXKb9esQZG9ciOmSh7r_x8Eadd2zDURRXE9s1_LrpGguirdF1IQSx_tKuMd7E3kVW19V5WLXn95dw2Rz62WoDdTz4jY1GgJoJ7DAVuuN67p626_5GPu9r--xGRu9zcxZ9L6PzKgK75WuklRAeJkXY9STogDtkNxzvj2etToFfV5vMv_YemhAOnMWX_hw2lKvtospvs5uuu__29KmTJ-SxNYRo2LD6KdnKimfk4aF19XhO_lhy0zKnLbmpJTdFclNLbloWtEdu2pKbduSmltz0JrkpkJvW5KY1uema3LQj9wsyn01PJgeOPTjEMVyopeOLVIEqq8H6Hblc8DQOuBeb3NPZyDUyyFMDpoWJtXFTnZskybjnapVLMF_iPDH8JdkpyiJ7TaiUoIIHxg10DLp2zhMhskC6qTFeYlKZD8iw_ccjY7Pq4-EuFxFY14hPBPhEiE8E-AwI66QXTTaZO-Q-AXg1Se4my4B8bLGNYE_AD31xkZWrq8gTMgA1HDTPAXnVYN0Nx7kAJQVb5AYLOgEccLOlOPtR551XHmhGUry5z-TekkfrR_cd2VlWq-w9qO_L5IPl9l9CUeP- |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+Complete+Bladder+Cuff+Removal+on+Oncological+Outcomes+Following+Radical+Nephroureterectomy+for+Upper+Tract+Urothelial+Carcinoma&rft.jtitle=Cancer+research+and+treatment&rft.au=%EB%A5%98%ED%98%84%EC%88%98&rft.au=%EA%B9%80%EC%A4%80%EA%B7%9C&rft.au=%EA%B9%80%ED%83%9C%EC%A7%84&rft.au=%EA%B0%95%EB%AF%BC%EC%9A%A9&rft.date=2021-07-01&rft.pub=%EB%8C%80%ED%95%9C%EC%95%94%ED%95%99%ED%9A%8C&rft.issn=1598-2998&rft.eissn=2005-9256&rft.spage=795&rft.epage=802&rft_id=info:doi/10.4143%2Fcrt.2020.919&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_9844207 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2998&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2998&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2998&client=summon |